ArticleGenes & genomics2026
A novel duplication mutation in the MYO7A gene associated with autosomal recessive hearing loss in a Chinese family.
Article in Genes & genomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundHearing loss (HL) is one of the most common sensory defects with genetic and environmental etiologies, which is classified into syndromic and non-syndromic hearing loss (NSHL). Variants in MYO7A have been found to result in non-syndromic hearing loss (DFNB2, DFNA11) and Usher Syndrome type 1B (USH1B). However, only a small number of variants result in DFNB2.
objectiveTo explore the pathogenic variant for a Chinese pedigree with autosomal recessive hearing loss (ARNSHL).
methodsThe clinical characteristics of the Chinese family were mainly showed by the audiological and ocular examinations. Exome sequencing and Sanger sequencing were utilized to identify the causative variant of the Chinese pedigree with ARNSHL, followed by molecular modeling analysis of effect of the variant on the protein function.
resultsThe affected patients currently simply exhibited symmetrical bilateral severe-to-profound neurosensory deafness at all frequencies without vestibular dysfunction or retinitis pigmentosa. We identified a novel duplication variant c.275_278dupACCT in the MYO7A gene using exome sequencing, which was further confirmed by Sanger sequencing. This homozygous variant was co-segregated with the ARNSHL phenotype in this Chinese family. Genetic mutation analysis and molecular modeling function prediction further supported the hypothesis that this novel homozygous variant is pathogenic.
conclusionThe novel homozygous variant c.275_278dupACCT (p.Ile94Profs*47) in MYO7A gene is responsible for this Chinese family with ARNSHL. Our results expand the spectrum of MYO7A variants and provide molecular insights into the pathogenesis of NSHL.
Indexed as
Identifiers
41359246What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.